CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

China flag China · Delayed Price · Currency is CNY
51.91
-0.68 (-1.29%)
May 30, 2025, 3:04 PM CST
70.81%
Market Cap 72.29B
Revenue (ttm) 1.93B
Net Income (ttm) -52.24M
Shares Out 1.39B
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 86.75
Dividend 0.02 (0.04%)
Ex-Dividend Date May 29, 2025
Volume 15,684,515
Average Volume 9,676,649
Open 55.38
Previous Close 52.59
Day's Range 51.11 - 60.00
52-Week Range 21.07 - 60.00
Beta 0.28
RSI 71.67
Earnings Date Aug 15, 2025

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, Ch... [Read more]

Industry Packaged Foods
Founded 2006
Employees 2,487
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300765
Full Company Profile

Financial Performance

In 2024, SHE:300765's revenue was 1.98 billion, a decrease of -21.98% compared to the previous year's 2.54 billion. Earnings were 53.73 million, a decrease of -87.63%.

Financial Statements

News

There is no news available yet.